First Page | Document Content | |
---|---|---|
Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for IndustryAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 463,83 KBShare Document on Facebook |